Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

MYGNMYGN
Showing 6 of 21 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in MYRIAD GENETICS INC

TWO SIGMA INVESTMENTS, LP holds 1.6M shares of MYGN (MYRIAD GENETICS INC), worth $8.9M as of 2026-Q2. The position was increased (+21.3% shares). MYGN represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$8.9M

Current Shares

1.6M

Total Value Change

+$8.8M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+21.3%
$8.9M0.0%$5.71
33
2026-Q1
Increased
1.3M
+40.3%
$5.8M0.0%$5.29
36
2025-Q4
Increased
915,171
+25.6%
$5.6M0.0%$6.17
33
2025-Q3
Increased
728,674
+33.8%
$5.3M0.0%$7.24
35
2025-Q2
Increased
544,454
+3654.9%
$2.9M0.0%$5.25
42
2025-Q1
New
14,500
-
$128,6150.0%$8.88
31

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used